SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001600132-17-000027
Filing Date
2017-03-20
Accepted
2017-03-20 16:20:42
Documents
3
Effectiveness Date
2017-03-20

Document Format Files

Seq Description Document Type Size
1 DEFA14A blphproxyamarch2017.htm DEFA14A 11786
2 blphnotice2017page1.jpg GRAPHIC 821073
3 blphnotice2017page2.jpg GRAPHIC 842023
  Complete submission text file 0001600132-17-000027.txt   2303742
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36845 | Film No.: 17701637
SIC: 2834 Pharmaceutical Preparations